VOLUNTARY ANNOUNCEMENT-NMPA APPROVAL OF IND APPLICATION FOR A PHASE IB/II CLINICAL TRIAL OF ELTANEXOR IN ADVANCED SOLID TUMORS

May 14, 2021View PDF